<DOC>
	<DOCNO>NCT00596115</DOCNO>
	<brief_summary>R ( + ) pramipexole dihydrochloride monohydrate [ R ( + ) PPX ] , experimental neuroprotective drug , provide open label extension study ALS patient participate earlier clinical protocol .</brief_summary>
	<brief_title>Treating Amyotrophic Lateral Sclerosis ( ALS ) With R ( + ) Pramipexole Dihydrochloride Monohydrate 60 mg/Day</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Definite diagnosis ALS No prior participation R ( + ) PPX clinical study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>